SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?


To: The Ox who wrote (7610)2/25/1999 1:24:00 PM
From: Osothebear_517  Respond to of 8359
 
In partial answer to your question, I would note to you that during the financial portion of the general meeting, the individual handling that portion stated that for the current year, there was no allowance made for income taxes since it would be a tactical impossibility for the company to be profitable in the current year.

He promised that there would be hard numbers available to quantify the integration charges by the end of the next quarter but the implication was that those charges would most likely not be recognized until the following quarter. He also stated that there would be a good look given to reevaluating goodwill. The determination in that regard could impact bottom line profitability into next year.

Aside from these bookkeeping matters, we were given to understand that there wasn't any reason to believe that projected revenues from operations would in any way be currently overstated which led me to believe that we were talking gross profitability next year subject to allowable charges.

The only caveat that was given in this regard was that as the integration process comes to completion, the company will for the first time be able to assess fully the amount of duplicative sales reporting which has taken place as a result of sales from one acquired company to another and then on to the ultimate consumer. Since these will now be treated as pass through sales, they will only impact gross revenues once. Any reduction in anticipated revenues will be more than offset by the reduction in sites and the employment downsizing which is envisioned for completion in the next 6-9 months.

OSO




To: The Ox who wrote (7610)2/25/1999 2:01:00 PM
From: c-man  Respond to of 8359
 
Michael, from my recollection, after taking write-downs (costs of acquisitions; layoffs, etc) and writeoffs (good will), both to be completed by June 30 per Randy Ingram (at meeting and during cc), ABTX expects to show a very slight profit after that. Even though they enter less-POTENTIALLY profitable quarters during the fall 1999, still I believe they are looking for minimal profits due to savings from layoffs, sales of excess real estate, capturing of synergies in distribution, etc. Interest expense should reduce as they use proceeds, presumably, to continue to whittle down debt, if not restructure the debt entirely for more-favorable terms (I thought Budd's comments about having a longstanding relationship w/ NationsBank was telling). Ingram made the point more than once that ABTX expects to be on the same Oracle dbase enterprise-wise by 6/30, and can and intends to offer specific guidance to analysts from that point forward. That's important to take the earnings uncertainty out of this stock. They can begin to model better and forcast earnings more accurately, for internal and external use, to make things more stable. I am assuming it's been sheer he** for them not being on similar accounting systems thus far...and explains 1) how they have routinely missed earnings projections, and 2) why they wait until the last day to file, now, for many qtrs in a row. Not saying it's right, or wrong....just trying to understand how they blew earnings so badly. I think Dr Thomas *really* mis-judged the impact blowing earnings so badly would have on both his perceived credibility, and ultimately the stock price. That is to say he didn't give this issue enough priority, and ultimately lost his position due to the fallout (my opinion only).

Bottom line - next calendar year is when I expect for tangible earnings to kick in. Not specifically sure what QTR ABTX is calling for though.

My personal opinion on that matter is this will not be an independent company beyond 1999, and really going out on a limb, by 8/30/99, so the issue of earnings I don't focus on as much. That may be simplistic and naive to some. I thought before, and continue to believe, that the intrinsic value of this company is not in earnings for ABTX's sake, but lies within their biotech and distribution value. If DLP, MYCO, and other more "mature" were still independent, waiting for a suitor, then I would take the position that perhaps ABTX will have to "go it alone" for a year or more on earnings alone while the other deals closed. But now that this *is* the last remaining seed company of any size, they are attractive for reasons well beyond earnings before end of year. You can tell I *still* believe Dr. Thomas' industry predictions were right on target...just could not agree with his execution overall and failure to maintain an acceptable stock price. While I didn't, per se, call for his departure, I can't say I disagree with it now.

When I saw the Cargill deal explode, I was cautiously optimistic ABTX would benefit.

c-man



To: The Ox who wrote (7610)2/25/1999 4:21:00 PM
From: drakes353  Read Replies (1) | Respond to of 8359
 
>>>Hey drakes? I am a bit surprised that your recent input on this thread has been to rub salt into other's wounds? This shows no class at all. I expect your gloating and calls for others to eat crow makes you feel better but adds little to our discussion. Maybe you can contribute to the thread?<<<

Gloating? Nah, not me.

Year end price target: $2-$3

Might have to lower that a bit based on....

....how much revenue they shed
....the number of shares they issue to stay afloat

Regards,

drakes353